Skip to content

Astrana Health ASTH Free cash flow yield

Free cash flow yield at other companies

CVS Health logo
CVS HealthCVS
8.1%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
3%+1.2pp
Agilon Health logo
Agilon HealthAGL
-47.6%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
5%
Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY
13.5%+7.8pp
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
5%-0.9pp

Other financials

Income statement

See full
Revenue$965.1M+55.6%
Gross profit$105.7M+48.2%
Operating income$28.5M+38.6%
Net income$14.4M+116%
EPS (diluted)$0.29+107%

Balance sheet

See full
Cash & equivalents$478.4M+85.0%
Total debt$1.1B+136%
Total equity$800.3M+7.4%
Total assets$2.4B+77.2%

Cash flow

See full
Operating cash flow$68.1M+309%
CapEx$4.0M+30.3%
Free cash flow$64.1M+372%

Valuation

See full
Market cap$2.04B-3.0%
Enterprise value$2.63B+22.0%
P/E67.6×
P/S0.6×-0.4×

Profitability

See full
Gross margin10.7%-1.3pp
Operating margin2.5%-1.1pp
Net margin0.9%
FCF margin4.6%

Returns & leverage

See full
Return on equity3.9%
Debt / equity1.3×+0.7×
Current ratio1.3×-0.4×

Where this comes from

Calculated from Astrana Health’s reported figures.

Based on trailing twelve months.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Astrana Health's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Astrana Health's free cash flow yield?
Astrana Health (ASTH) reported free cash flow yield of 11.8% in Q1 2026.
What is the long-term trend for Astrana Health's free cash flow yield?
Over 3 years (2020 to 2025), Astrana Health's free cash flow yield has grown at a 7.1% compound annual growth rate (CAGR), from 7.2% to 8.9%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.